Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Apmonia Therapeutics
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.
Apmonia Therapeutics
Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.
TL;DR
Founded: 2019
Headquarters: Reims, France
Focus: Peptide-based anti-cancer immunotherapies targeting the tumor microenvironment
Lead program: AP-01 (TAX2) — peptide antagonist of thrombospondin-1/CD47
Employees: 6
Total funding: €14,700,000
Company Overview
Problem Domain
Cancer immunotherapy; tumor microenvironment modulation
Founded
2019
Industry
Biotechnology
Funding Track Record
Most recent financing activity reported on this date; company has received support from EIC Accelerator and France 2030 (grants and equity awards).
Investor Signal
“Received support from the European Innovation Council (EIC Accelerator) and France 2030 (public/state-backed funding and grants)”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
65,000+
Open Roles
1,300+
New This Week